N. WINDHAM, Maine, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, today announced that it received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) on August 20, 2026, indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) due to the delayed filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 (the “Q2 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Listing Rule requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC.
The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.
In accordance with Nasdaq’s listing rules, the Company has 60 calendar days after the Notice, or until October 19, 2026, to submit a plan of compliance to Nasdaq addressing how the Company intends to regain compliance with the Listing Rule. Pursuant to the Notice, Nasdaq has the discretion to grant the Company up to 180 calendar days from the Q2 Form 10-Q’s due date, or February 10, 2027, for the Company to regain compliance with the Listing Rule.
At this time, the Company is unable to predict when, or whether, the Q2 Form 10-Q will be filed. There can be no assurance that the Company will file the Q2 Form 10-Q or otherwise regain compliance with the Listing Rule.
About Synergy CHC Corp.
Synergy CHC Corp. develops and markets consumer health and wellness products, led by its flagship brands FOCUSfactor® and Flat Tummy®. FOCUSfactor®, a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution in the U.S., Canada and Mexico through major retailers including Walmart, Amazon, BJ’s, and Walgreens, among others. Flat Tummy® complements Synergy’s portfolio as a lifestyle brand focused on women's wellness and weight management.
Disclosure Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are generally identified by the use of forward-looking terminology, including the terms “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “likely,” “may,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and, in each case, their negative or other various or comparable terminology. All statements other than statements of historical facts contained in this press release are forward-looking statements. In particular, forward-looking statements include, among other things, statements relating to the Company's efforts to regain compliance with Nasdaq Listing Rule 5250(c)(1), the submission and potential acceptance of a compliance plan by Nasdaq, the possibility of any extension that may be granted by Nasdaq, and the timing of any future SEC filings. These forward-looking statements are not guarantees of future results and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond our control. Important factors that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, a material delay in the Company’s financial reporting, uncertainties about the timing of the Company’s submission of a compliance plan, Nasdaq’s acceptance of any such plan, the duration of any extension that may be granted by Nasdaq, and the risk that the Company will be unable to meet Nasdaq’s continued listing requirements. We disclaim and do not undertake any obligation to update or revise any forward-looking statement in this report, except as required by applicable law or regulation. Given these uncertainties, you should not place undue reliance on these forward-looking statements.
Investor Relations
Gateway Group
Cody Slach, Greg Robles
949.574.3860
SNYR@gateway-grp.com
View the Zacks #1 Rank List
Synergy CHC Corp. Receives Nasdaq Non-Compliance Notice Over Delayed Q2 2026 Form 10-Q Filing
Synergy CHC Corp. faces Nasdaq non-compliance due to delayed Q2 report, with a compliance plan due by October 19, 2026.
Quiver AI Summary
Synergy CHC Corp. announced that it received a notice from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) due to delays in filing its Quarterly Report on Form 10-Q for the quarter ending June 30, 2026. The notice, received on August 20, 2026, does not immediately affect the trading of the company's stock, but Synergy has 60 days to submit a plan to regain compliance. Nasdaq may grant an extension of up to 180 days for the company to meet the necessary requirements. Currently, Synergy cannot predict the timing of the filing and there are no assurances it will regain compliance. Synergy CHC Corp. is known for its consumer health products, including FOCUSfactor® and Flat Tummy®.
Potential Positives
Potential Negatives
FAQ
What is the Nasdaq notice received by Synergy CHC Corp.?
Synergy received a notice from Nasdaq for not complying with Listing Rule 5250(c)(1) due to a delayed filing of its Q2 Form 10-Q.
What are the implications of the Nasdaq notice for Synergy's stock?
The notice has no immediate effect on the listing or trading of Synergy's common stock on Nasdaq.
How long does Synergy have to regain compliance with Nasdaq?
Synergy has 60 calendar days from the notice, until October 19, 2026, to submit a compliance plan to Nasdaq.
What are Synergy's flagship products?
Synergy's flagship brands include FOCUSfactor®, a brain health supplement, and Flat Tummy®, focused on women's wellness and weight management.
Are there any risks related to Synergy's future filings?
Yes, there are risks including potential delays in financial reporting and uncertainties regarding the acceptance of the compliance plan by Nasdaq.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SNYR Revenue
$SNYR had revenues of $5.5M in Q1 2026. This is a decrease of -32.77% from the same period in the prior year.
You can track SNYR financials on Quiver Quantitative's SNYR stock page.
You can access data on SNYR stock through the Quiver Quantitative API.
$SNYR Hedge Fund Activity
We have seen 12 institutional investors add shares of $SNYR stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$SNYR Analyst Ratings
Wall Street analysts have issued reports on $SNYR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
To track analyst ratings and price targets for $SNYR, check out Quiver Quantitative's $SNYR forecast page.
Full Release
N. WINDHAM, Maine, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a consumer health and wellness company, today announced that it received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) on August 20, 2026, indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) due to the delayed filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 (the “Q2 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Listing Rule requires companies with securities listed on Nasdaq to timely file all required periodic reports with the SEC.
The Notice has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.
In accordance with Nasdaq’s listing rules, the Company has 60 calendar days after the Notice, or until October 19, 2026, to submit a plan of compliance to Nasdaq addressing how the Company intends to regain compliance with the Listing Rule. Pursuant to the Notice, Nasdaq has the discretion to grant the Company up to 180 calendar days from the Q2 Form 10-Q’s due date, or February 10, 2027, for the Company to regain compliance with the Listing Rule.
At this time, the Company is unable to predict when, or whether, the Q2 Form 10-Q will be filed. There can be no assurance that the Company will file the Q2 Form 10-Q or otherwise regain compliance with the Listing Rule.
About Synergy CHC Corp.
Synergy CHC Corp. develops and markets consumer health and wellness products, led by its flagship brands FOCUSfactor® and Flat Tummy®. FOCUSfactor®, a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution in the U.S., Canada and Mexico through major retailers including Walmart, Amazon, BJ’s, and Walgreens, among others. Flat Tummy® complements Synergy’s portfolio as a lifestyle brand focused on women's wellness and weight management.
Disclosure Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are generally identified by the use of forward-looking terminology, including the terms “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “likely,” “may,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and, in each case, their negative or other various or comparable terminology. All statements other than statements of historical facts contained in this press release are forward-looking statements. In particular, forward-looking statements include, among other things, statements relating to the Company's efforts to regain compliance with Nasdaq Listing Rule 5250(c)(1), the submission and potential acceptance of a compliance plan by Nasdaq, the possibility of any extension that may be granted by Nasdaq, and the timing of any future SEC filings. These forward-looking statements are not guarantees of future results and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond our control. Important factors that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, a material delay in the Company’s financial reporting, uncertainties about the timing of the Company’s submission of a compliance plan, Nasdaq’s acceptance of any such plan, the duration of any extension that may be granted by Nasdaq, and the risk that the Company will be unable to meet Nasdaq’s continued listing requirements. We disclaim and do not undertake any obligation to update or revise any forward-looking statement in this report, except as required by applicable law or regulation. Given these uncertainties, you should not place undue reliance on these forward-looking statements.
Investor Relations
Gateway Group
Cody Slach, Greg Robles
949.574.3860
SNYR@gateway-grp.com
Read full article here »